Funds managed by KKR, a global investment firm and Quadrantis Capital, a Portuguese investment management business, have entered into definitive agreements to acquire minority stakes in Hong Kong-based global reinsurer, Peak Reinsurance Company Limited (Peak Re), via Peak Reinsurance Holdings Limited.The transactions are expected to close in the fourth quarter of 2025, subject to customary closing conditions, including regulatory approvals. Peak Re says that the agreements are not anticipated to affect its ...

KKR & Co. and Quadrantis Capital agreed to acquire minority stakes in Hong Kong-based Peak Reinsurance Co.KKR and Quadrantis will hold about 11.3% and 1.8% of Peak Re, respectively, after the deal is completed, according to a statement Tuesday, which confirmed an earlier Bloomberg News report. Fosun International Ltd. will hold the remaining 86.7% in the reinsurer. Prudential Financial Inc. has sold its indirect holding of about 13.1% in Peak Re following the deal with KKR and Quadrantis. The transaction is ...

Core Insights - The World Intellectual Property Organization (WIPO) has reported that China has successfully risen to the top ten in the Global Innovation Index, highlighting significant progress in technology research and innovation ecosystem development [1] - The upcoming 20th Central Committee meeting is expected to focus on innovation as a key direction for the 14th Five-Year Plan, increasing market attention on companies' technological innovations and strategies [1] Group 1: Company Performance - Fosun International has demonstrated steady revenue and profit growth driven by its core capabilities in innovation and globalization, with a recommendation to "buy" from multiple brokerages [1][2] - The company has made breakthroughs in innovative drugs, including HLX43, a PD-L1 antibody-drug conjugate currently undergoing clinical trials in several countries, positioning it as a potential effective cancer treatment [2] Group 2: Globalization Strategy - Fosun has built a global research, registration, and marketing capability over the past decade, with its biopharmaceutical products reaching nearly 60 countries and benefiting over 850,000 patients [3] - The company’s core product for breast cancer treatment, Hanquyou, has been approved in over 50 countries, showcasing its global reach [3] Group 3: Technological Innovation - Fosun is embracing AI applications across its business sectors, with significant growth in its tourism segment, where the core area of Yuyuan Mall achieved a GMV of RMB 2.6 billion, a 55% year-on-year increase [3] - In the tourism sector, Fosun's Club Med is enhancing its digital services through AI, providing personalized 24/7 support across multiple countries [4] Group 4: Financial Strength - The company has shown robust financing capabilities and an optimized financial structure, with several brokerages expressing confidence in its financial health [5] - In September, Fosun secured a sustainable syndicated loan of $910 million, setting a record for offshore loans for private enterprises in 2025, reflecting strong market confidence in its future [5]

Core Insights - The World Intellectual Property Organization (WIPO) has reported that China has successfully risen to the top ten in the global innovation index, highlighting significant progress in technology research and innovation ecosystem development [1] - The upcoming 20th Central Committee meeting is expected to focus on innovation as a key direction for the 14th Five-Year Plan, increasing market attention on companies' technological innovations and strategies [1] Group 1: Company Performance - Fosun International has demonstrated steady revenue and profit growth driven by its core capabilities in innovation and globalization, with a positive outlook from multiple securities firms [1][2] - The company has received "buy" or "hold" ratings from various institutions, with target prices ranging from 6.5 to 7.5 HKD [1] Group 2: Innovation and Drug Development - Fosun has made significant advancements in its health sector, with innovative drugs like HLX43, a PD-L1 antibody-drug conjugate, undergoing clinical trials in multiple countries [2] - The company has also achieved breakthroughs with its self-developed targeted drug, Fumainin, which has been approved for rare disease indications, filling treatment gaps in oncology [2] Group 3: Globalization Strategy - Fosun has built a global research, registration, and marketing capability over the past decade, with its biopharmaceutical products reaching nearly 60 countries and benefiting over 850,000 patients [3] - The company has established a leading platform for small molecule innovation and has completed over 800 regulatory applications globally, with more than 600 approvals [3] Group 4: AI and Digital Transformation - Fosun is leveraging AI across various business sectors, enhancing customer experiences in tourism and improving operational efficiency in insurance [4] - The company has partnered with Alibaba Cloud to develop an AI-driven tourism assistant, significantly enhancing customer service capabilities [4] Group 5: Financial Strength and Capital Operations - Fosun has shown robust financing capabilities and an optimized financial structure, with a recent syndicate loan agreement reaching a record high of 9.1 billion USD equivalent [5] - The company is expected to continue optimizing its asset structure following recent interest rate cuts by the Federal Reserve, maintaining financial stability [5]

中国·澄迈国际经济贸易洽谈会活动现场。海南日报全媒体记者 高懿 摄 本次经洽会坚持以"聚焦出海 投资澄迈"为主题，不再是一场以地域为名的招商大会，而是一场注重产业 投资与要素流动，打造"经济品牌"，解决"如何落地、如何发展"的"产业落地型"招商盛会。 此次大会放弃"大而全"的路径，选择"专而精"的赛道，深度聚焦数字经济、油气服务、沉香产业、跨境 电商、新能源汽车、基金产业、游戏产业等垂直领域，形成极高的专业性和不可替代性。 "这就使澄迈成为全球相关领域投资者进入海南的首选门户和权威平台。"作为已经落地澄迈的基金公 司，中复资本董事长袁立接受海南日报全媒体记者采访时建议，澄迈可充分利用海南自贸港政策，吸引境内 外资本集聚，澄迈还可主动对接北上广深等城市，推动澄迈基金与全国核心资源建立强连接，实现双向流 动。 海南日报全媒体记者 高懿 10月18日，2025中国·澄迈国际经济贸易洽谈会(以下简称澄迈经洽会)在华东师范大学澄迈实验中学澄澜 文体中心开幕。 随着大会议程的深入，"澄迈"两字的热度不断升高：它成为留在一众客商朋友圈里的关键词，手机通讯 录中不断增加的人脉资源，更成为投资者视野中的"产业高地"和"投资热土 ...

值得一提的是，大会发布了由上海交通大学上海高级金融学院(高金/SAIF)牵头撰写的《践行可持续发 展之路——2025上海ESG发展报告》(以下简称"报告")。该报告为全球可持续发展贡献了"上海方案"。 报告指出，与前一年相比，2025年上海ESG发展正在走向制度更系统、行动更标准、绩效更量化、协同 更紧密的新阶段。政府与监管机构在制度供给和治理创新方面发挥了核心作用。上海在政策落地过程中 积极探索与国际标准接轨，为各类主体提供方向和指南，为ESG实践的规范化和规模化奠定了基础。 报告还深入剖析了上海ESG生态体系中的各方参与者在推动ESG发展过程中发挥的作用。报告指出，企 业是上海ESG生态中的中坚力量，国有企业在信息披露和治理方面起到示范作用，民营与外资企业则在 绿色产品开发、供应链协同和社会责任实践中开展多样化探索；然而，中小企业面临理念和能力受限， 技术与资金门槛高，治理体系落实难度大等困难，ESG价值体现与资本化进程缓慢，遭遇推广瓶颈。报 告还指出，人才培养与公众参与正成为推动上海ESG持续发展的重要动力。同时，国际合作与涉外企业 的典型范例在上海ESG生态建设中的作用也日益凸显。 本届可持续全球领导 ...

资料图。 复星、舍得做酒旅负负能得正？ 徐爱之 对陷入业绩下滑困境的舍得酒业来说，有探索精神是好的，哪怕不能成功。 选择在营收和利润下滑时进入酒旅业，可能是舍得穿越周期活下去的最佳选择，尤其四年前复 星国际的进入，为舍得注入新能量：经验、品牌、资金和资源。 舍得此举，更像是对外宣扬他们其实是有实力来做酒旅的，尽管看起来像是一场豪赌，却也不 乏长远格局。 01. 与其说是豪赌，更像是无路可退 舍得酒业业绩变差不是从去年开始的。 虽然 2024 年对这家川酒六金花之一的酒厂而言，是财报最难看的一年。需要承认的是，白酒市 场进入存量竞争，资源越发集中到头部几个品牌中，茅台、五粮液的日子再不好过，也比腰线 酒企容易得多。消费变级、政策环境影响、年轻群体需求变化，让白酒企业在今日面临比过去 更严重的挑战，全国白酒行业都进入深度调整期。 国家统计局数据显示， 2024 年全国规模以上白酒产量同比下降 1.86% 至 414.5 万千升，连续 8 年下滑，行业产能收缩宏观趋势明显。产量下降、库存压力高企。中国酒业协会 2024 年中期报 告显示， 20 家白酒上市公司存货总额达 1490.95 亿元，同比增长 12% ，超 ...

专题：2025可持续全球领导者大会&首届绿色产业与可持续消费博览会 10月16日，2025可持续全球领导者大会在上海举行。大会以"携手应对挑战：全球行动、创新与可持续 增长"为主题，包括诺贝尔奖得主、图灵奖得主、全球500强企业负责人等在内的约500位中外嘉宾参 会。 复星国际联席董事长汪群斌应邀作题为《以创新驱动：复星全球化攀登之路》的演讲，分享了复星如何 在全球化征程中，以创新为核心驱动力，实现商业价值与社会价值的双赢。 汪群斌表示："作为一家创新驱动的全球家庭消费产业集团，复星成立三十余年来始终秉持'助天下'的 初心，将全球化视野与本地化深耕相结合，将科技创新与社会责任相融合，走出一条创新驱动、责任引 领的可持续发展之路。" 以创新，满足全球家庭未被满足的需求 "创新的最高境界，是让生命不留遗憾。"汪群斌表示，"在健康领域，创新不是论文上的数字，而是患 者眼中的希望。每一个未被满足的医疗需求背后，都是一个渴望健康的家庭。" 他以复星自主研发的创新型抗PD-1单抗H药汉斯状为例，进一步阐释复星对创新的理解。 肺癌是全球发病率和死亡率最高的恶性肿瘤，而小细胞肺癌是其中侵袭性最强的亚型，约80%的患者首 次确 ...

专题：2025可持续全球领导者大会&首届绿色产业与可持续消费博览会 10月16日，2025可持续全球领导者大会在上海举行。大会以"携手应对挑战：全球行动、创新与可持续 增长"为主题，包括诺贝尔奖得主、图灵奖得主、全球500强企业负责人等在内的约500位中外嘉宾参 会。 复星国际联席董事长汪群斌应邀作题为《以创新驱动：复星全球化攀登之路》的演讲，分享了复星如何 在全球化征程中，以创新为核心驱动力，实现商业价值与社会价值的双赢。 汪群斌表示："作为一家创新驱动的全球家庭消费产业集团，复星成立三十余年来始终秉持'助天下'的 初心，将全球化视野与本地化深耕相结合，将科技创新与社会责任相融合，走出一条创新驱动、责任引 领的可持续发展之路。" 以创新，满足全球家庭未被满足的需求 "创新的最高境界，是让生命不留遗憾。"汪群斌表示，"在健康领域，创新不是论文上的数字，而是患 者眼中的希望。每一个未被满足的医疗需求背后，都是一个渴望健康的家庭。" 他以复星自主研发的创新型抗PD-1单抗H药汉斯状为例，进一步阐释复星对创新的理解。 以创新，参与全球价值创造 作为最早"出海"的中国民营企业之一，复星在全球超过40个国家和地区持续深 ...

10月15日，全联旅游业商会"十五五"旅游发展与金融服务旅游经济发展座谈会在太仓阿尔卑斯国际度假 区举行。 《中国经营报》记者了解到，会上，复星国际联席CEO、复星旅文董事长徐晓亮发表主旨演讲。他表 示，随着旅游业正从"观光游"迈向"度假游"，加大优质旅游产品供给、精准满足人民群众个性化与高品 质的旅游消费需求，已成为推动旅游业高质量发展的核心抓手。 在徐晓亮看来，"十五五"时期，是以中国式现代化全面推进强国建设、民族复兴的关键五年，也是我国 从旅游大国迈向旅游强国的攻坚期。加大优质旅游产品供给、精准满足人民群众日益增长的个性化、高 品质旅游消费需求，已成为推动旅游业高质量发展、加快建设旅游强国的核心抓手。 徐晓亮进一步表示，复星旅文的使命"度假让生活更美好"，与"十五五"规划中"旅游业更好服务美好生 活"的目标高度契合。未来，复星旅文将持续打造世界级度假产品，积极融入"十五五"旅游强国建设进 程。 截至目前，复星旅文在全球经营着近70个度假村和酒店，遍布全球五大洲超过40个国家与地区，年营收 超过190亿元，每年接待宾客超过860万人次。经过不断的发展，形成了四大产品线：Club Med全球、 Club M ...